Pfizer and BioNtech came out with promising results on their Phase 2/3 study for the vaccine for children between ages 5 and 11.
According to a press release on Sept. 20, the trial showed “robust...
On Aug. 23, the Food and Drug Administration finally approved the Pfizer-BioNTech COVID-19 vaccine, eight months after the vaccine became available to the public under emergency use authorization, paving...
